Trade ALX Oncology Holdings Inc. - ALXO CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.57 |
| Open | 0.52 |
| 1-Year Change | -96.79% |
| Day's Range | 0.5 - 0.59 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 0.57 | -0.02 | -3.39% | 0.59 | 0.61 | 0.56 |
| Apr 23, 2025 | 0.56 | -0.02 | -3.45% | 0.58 | 0.64 | 0.55 |
| Apr 22, 2025 | 0.57 | 0.02 | 3.64% | 0.55 | 0.57 | 0.52 |
| Apr 21, 2025 | 0.54 | 0.02 | 3.85% | 0.52 | 0.55 | 0.51 |
| Apr 17, 2025 | 0.52 | -0.01 | -1.89% | 0.53 | 0.55 | 0.52 |
| Apr 16, 2025 | 0.53 | 0.01 | 1.92% | 0.52 | 0.55 | 0.51 |
| Apr 15, 2025 | 0.52 | 0.03 | 6.12% | 0.49 | 0.52 | 0.48 |
| Apr 14, 2025 | 0.48 | -0.02 | -4.00% | 0.50 | 0.50 | 0.46 |
| Apr 11, 2025 | 0.46 | 0.02 | 4.55% | 0.44 | 0.50 | 0.44 |
| Apr 10, 2025 | 0.45 | -0.04 | -8.16% | 0.49 | 0.50 | 0.44 |
| Apr 9, 2025 | 0.49 | 0.00 | 0.00% | 0.49 | 0.52 | 0.47 |
| Apr 8, 2025 | 0.48 | -0.03 | -5.88% | 0.51 | 0.55 | 0.48 |
| Apr 7, 2025 | 0.51 | -0.01 | -1.92% | 0.52 | 0.54 | 0.47 |
| Apr 4, 2025 | 0.49 | -0.02 | -3.92% | 0.51 | 0.51 | 0.46 |
| Apr 3, 2025 | 0.51 | -0.05 | -8.93% | 0.56 | 0.56 | 0.51 |
| Apr 2, 2025 | 0.56 | -0.02 | -3.45% | 0.58 | 0.60 | 0.55 |
| Apr 1, 2025 | 0.59 | 0.00 | 0.00% | 0.59 | 0.60 | 0.57 |
| Mar 31, 2025 | 0.60 | -0.04 | -6.25% | 0.64 | 0.64 | 0.57 |
| Mar 28, 2025 | 0.63 | -0.07 | -10.00% | 0.70 | 0.70 | 0.63 |
| Mar 27, 2025 | 0.68 | 0.01 | 1.49% | 0.67 | 0.69 | 0.63 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
ALX Oncology Holdings Inc. Company profile
About ALX Oncology Holdings Inc
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company. The Company is focused on enabling patients to fight cancer by developing therapies that block the cluster of differentiation 47 (CD47) checkpoint pathway and bridge the innate and adaptive immune system. The Company is developing a checkpoint inhibitor designed to have an affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches. Its lead product candidate, ALX148, is a CD47 blocking therapeutic. ALX148 is a fusion protein that combines a CD47 binding domain with its inactivated fragment crystallizable (Fc) domain. The CD47 binding domain of ALX148 is an affinity enhanced extracellular domain of signal regulatory protein alpha (SIRPa), a protein that is the natural receptor to CD47 found on myeloid cells. Its programs are focused on targeting CD47 across various oncology indications.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, ALX Oncology Holdings Inc revenues decreased from $1.2M to $0K. Net loss applicable to common stockholders increased 64% to $83.5M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Reserach and developement increase of 76% to $46.5M (expense).
| Industry: | Bio Therapeutic Drugs |
323 Allerton Avenue
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com